These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34541964)

  • 1. Management of non-alcoholic fatty liver disease in patients with sarcopenia.
    Hsu CS; Kao JH
    Expert Opin Pharmacother; 2022 Feb; 23(2):221-233. PubMed ID: 34541964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity.
    Rachakonda V; Wills R; DeLany JP; Kershaw EE; Behari J
    Obesity (Silver Spring); 2017 Aug; 25(8):1360-1368. PubMed ID: 28605159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications.
    Fernández-Mincone T; Contreras-Briceño F; Espinosa-Ramírez M; García-Valdés P; López-Fuenzalida A; Riquelme A; Arab JP; Cabrera D; Arrese M; Barrera F
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1141-1157. PubMed ID: 32811209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice.
    El Sherif O; Dhaliwal A; Newsome PN; Armstrong MJ
    Expert Rev Gastroenterol Hepatol; 2020 Mar; 14(3):197-205. PubMed ID: 32064966
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease.
    Kawaguchi T; Takahashi H; Gerber LH
    Clin Liver Dis; 2023 May; 27(2):275-286. PubMed ID: 37024207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
    Nseir W; Hellou E; Assy N
    World J Gastroenterol; 2014 Jul; 20(28):9338-44. PubMed ID: 25071328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease.
    Himoto T; Miyatake K; Maeba T; Masaki T
    Can J Gastroenterol Hepatol; 2020; 2020():3576974. PubMed ID: 32695733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
    Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
    Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenic obesity.
    Polyzos SA; Margioris AN
    Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Bhanji RA; Narayanan P; Allen AM; Malhi H; Watt KD
    Hepatology; 2017 Dec; 66(6):2055-2065. PubMed ID: 28777879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
    Cui H; Zhang X
    J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease.
    Kim A; Krishnan A; Hamilton JP; Woreta TA
    Gastroenterol Clin North Am; 2021 Mar; 50(1):217-241. PubMed ID: 33518166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
    Al-Dayyat HM; Rayyan YM; Tayyem RF
    Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Younossi ZM; Corey KE; Lim JK
    Gastroenterology; 2021 Feb; 160(3):912-918. PubMed ID: 33307021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease.
    Iwaki M; Kobayashi T; Nogami A; Saito S; Nakajima A; Yoneda M
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
    Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
    Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.